111 EBITDA Margin 2018-2024 | YI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for 111 (YI) over the last 10 years. The current EBITDA margin for 111 as of June 30, 2024 is .
111 EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-06-30 $2.05B $-0.04B -1.91%
2024-03-31 $2.06B $-0.05B -2.19%
2023-12-31 $2.11B $-0.05B -2.33%
2023-09-30 $2.09B $-0.03B -1.63%
2023-06-30 $2.05B $-0.03B -1.66%
2023-03-31 $2.03B $-0.04B -1.97%
2022-12-31 $1.96B $-0.05B -2.71%
2022-09-30 $1.96B $-0.06B -2.91%
2022-06-30 $2.01B $-0.07B -3.64%
2022-03-31 $2.02B $-0.09B -4.45%
2021-12-31 $1.95B $-0.10B -5.13%
2021-09-30 $1.84B $-0.11B -5.82%
2021-06-30 $1.67B $-0.10B -5.87%
2021-03-31 $1.43B $-0.08B -5.73%
2020-12-31 $1.26B $-0.07B -5.72%
2020-09-30 $0.99B $-0.07B -7.14%
2020-06-30 $0.80B $-0.07B -8.74%
2020-03-31 $0.69B $-0.07B -10.39%
2019-12-31 $0.57B $-0.07B -12.68%
2019-09-30 $0.45B $-0.07B -14.99%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.056B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $10.500B 0.00
Hims & Hers Health (HIMS) United States $5.733B 148.28
Inspire Medical Systems (INSP) United States $5.716B 178.27
Axonics (AXNX) United States $3.603B 1762.25
IRhythm Technologies (IRTC) United States $2.729B 0.00
Privia Health (PRVA) United States $2.710B 225.80
Enovis (ENOV) United States $2.621B 17.77
Omnicell (OMCL) United States $2.264B 74.08
Azenta (AZTA) United States $2.250B 112.17
10x Genomics (TXG) United States $1.898B 0.00
Schrodinger (SDGR) United States $1.620B 0.00
Clover Health Investments (CLOV) United States $1.617B 0.00
Phreesia (PHR) United States $1.235B 0.00
Standard BioTools (LAB) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.569B 0.00
Definitive Healthcare (DH) United States $0.528B 91.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.278B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.261B 0.00
TruBridge (TBRG) United States $0.234B 67.96
P3 Health Partners (PIII) United States $0.140B 0.00
American Well (AMWL) United States $0.136B 0.00
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00